135 related articles for article (PubMed ID: 37365217)
21. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
Zhao T; Liao B; Yao J; Liu J; Huang R; Shen P; Peng Z; Gui H; Chen X; Zhang P; Zhu Y; Li X; Wei Q; Zhou Q; Zeng H; Chen N
Prostate; 2015 Feb; 75(3):225-32. PubMed ID: 25307858
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.
Zhao J; Liu J; Sun G; Zhang M; Chen J; Shen P; Liu Z; Liao B; Zhang X; Gong J; Chen N; Zeng H;
J Urol; 2019 Apr; 201(4):759-768. PubMed ID: 30652989
[TBL] [Abstract][Full Text] [Related]
23. Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors over the Past 2 Decades.
Bangolo A; Fwelo P; Iyer KM; Klinger S; Tavares L; Dey S; Chacko AA; Hein M; Gudena S; Lawal G; Sivasubramanian BP; Rimba Z; Hirpara K; Merajunnissa M; Veliginti S; Arana G; Sathyarajan DT; Singh S; Shetty T; Bhardwaj K; Hashemy S; Duran RL; Kim SH; Hipolito CM; Yoon K; Patel V; Alshimari A; Inban P; Yasmeen S; Devanaboyina K; Kumar G; Preet S; Akhtar M; Abdi A; Nalajala N; Rizvi SFM; Gupta B; Weissman S
Diseases; 2023 May; 11(2):. PubMed ID: 37218887
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
Huang J; Huang D; Yan J; Chen T; Gao Y; Xu D; Na R
Cancer Med; 2020 Dec; 9(24):9409-9418. PubMed ID: 33141518
[TBL] [Abstract][Full Text] [Related]
25. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract][Full Text] [Related]
26. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
Au S; Villamil CF; Alaghehbandan R; Wang G
Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer characteristics and cancer-specific mortality of Native American patients.
Deuker M; Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Tian Z; Saad F; Chun F; Karakiewicz PI
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):277-285. PubMed ID: 31695139
[TBL] [Abstract][Full Text] [Related]
28. Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer.
Chierigo F; Wenzel M; Würnschimmel C; Flammia RS; Horlemann B; Tian Z; Saad F; Chun FKH; Graefen M; Gallucci M; Shariat SF; Mantica G; Borghesi M; Suardi N; Terrone C; Karakiewicz PI
J Urol; 2022 Feb; 207(2):375-384. PubMed ID: 34555930
[TBL] [Abstract][Full Text] [Related]
29. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
[TBL] [Abstract][Full Text] [Related]
30. Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer.
Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
Prostate; 2022 May; 82(6):740-750. PubMed ID: 35226380
[TBL] [Abstract][Full Text] [Related]
31. The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer: a real-world study from the SEER database.
Yuan QM; Lin TH; Jin K; Qiu S; Zhou XH; Jin D; Li JK; Yang L; Wei Q
Asian J Androl; 2022; 24(3):305-310. PubMed ID: 34596600
[TBL] [Abstract][Full Text] [Related]
32. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
33. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
34. PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions.
Deuker M; Stolzenbach LF; Pecoraro A; Rosiello G; Luzzago S; Tian Z; Saad F; Chun FK; Karakiewicz PI
World J Urol; 2021 Mar; 39(3):787-796. PubMed ID: 32458094
[TBL] [Abstract][Full Text] [Related]
35. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT
J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database.
Wang Y; Zhou Y; Chen Y; Xia R; Liu J
Technol Cancer Res Treat; 2022; 21():15330338221106533. PubMed ID: 35770310
[No Abstract] [Full Text] [Related]
37. Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis.
An N; Leng X; Wang X; Sun Y; Chen Z
Lung Cancer; 2020 Apr; 142():13-19. PubMed ID: 32062199
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
40. Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.
Jin D; Qiu S; Jin K; Zhou X; Cao Q; Yang L; Wei Q
Front Oncol; 2020; 10():653. PubMed ID: 32500022
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
